Characteristic Physical Properties and Structural Fragments of Marketed Oral Drugs

Journal of Medicinal Chemistry

Volumn 47, Issue 1, 2004, Pages 224-232

  Vieth, Michal ^a   Siegel, Miles G ^a   Higgs, Richard E ^a   Watson, Ian A ^a   Robertson, Daniel H ^a   Savin, Kenneth A ^a   Durst, Gregory L ^a   Hipskind, Philip A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; CLOXACILLIN; FLUOXETINE; NYSTATIN;

ARTICLE; CHEMICAL BOND; DRUG INFORMATION; DRUG MARKETING; DRUG STRUCTURE; HYDROGEN BOND; INJECTION; ORAL DRUG ADMINISTRATION; STATISTICAL ANALYSIS; STRUCTURE ACTIVITY RELATION;

ADMINISTRATION, ORAL; CHEMISTRY, PHYSICAL; INJECTIONS; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; STATISTICS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0347361638     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030267j     Document Type: Article

References (30)

1. Proudfoot, J. R. Drugs, leads, and drug-likeness: an analysis of some recently launched drugs. Bioorg. Med. Chem. Lett. 2002, 12, 1647-1650.
2. Muegge, I. Selection Criteria for Drug-like Compounds. Med. Res. Rev. 2003, 23, 302-321.
3. Lipinski, C. A. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods 2000, 44, 235-249.
4. Walters, W. P.; Ajay, X.; Murcko, M. A. Recognizing molecules with drug-like properties. Curr. Opin. Chem. Biol. 1999, 3, 384-387.
5. Walters, W. P.; Murcko, M. A. Prediction of "drug-likeness". Adv. Drug Delivery Rev. 2002, 54, 255-271.
6. Muegge, I.; Heald, S. L.; Brittelli, D. Simple selection criteria for drug-like chemical matter. J. Med. Chem. 2001, 44, 1841-1846.
7. Egan, W. J.; Walters, W. P.; Murcko, M. A. Guiding molecules towards drug-likeness. Curr. Opin. Drug Discovery Dev. 2002, 5, 540-549.
8. Podlogar, B.; Muegge, I.; Brice, L. Computational methods to estimate drug development parameters. Curr. Opin. Drug Discovery Dev. 2001, 4, 102-109.
9. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 1997, 23, 3-25.
10. Palm, K.; Stenberg, P.; Luthman, K.; Artursson, P. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm. Res. 14, 568-571.
11. Sakaeda, T.; Okamura, N.; Nagata, S.; Yagami, T.; Horinouchi, M.; et al. Molecular and pharmacokinetic properties of 222 commercially available oral drugs in humans. Biol. Pharm. Bull. 2001, 24, 935-940.
12. Veber, D. F.; Johnson, S. R.; Cheng, H. Y.; Smith, B. R.; Ward, K. W.; et al. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 2002, 45, 2615-2623.
13. MDL Drug Data Report, version 2002.2; MDL Information Systems Inc.; San Leandro, CA, 2002.
14. Available Chemicals Directory (ACD), version 2002.2; MDL Information Systems Inc.: San Leandro, CA, 2002.
15. MICROMEDEX, T. MICROMEDEX(R) Healthcare Series; Micromedex, Inc.: Englewood, CO, 2003; Vol. 115.
16. Comprehensive Medicinal Chemistry, CMC; MDL Information Systems Inc.: San Leandro, CA, 2002.
17. SciFinder, 2001 ed.; American Chemical Society: Washington, DC, 2002.
18. Food and Drug Administration Orange Book, 22 ed., U.S. Food and Drug Administration: Washington, DC, 2003.
19. Wenlock, M. C.; Austin, R. P.; Barton, P.; Davis, A. M.; Leeson, P. D. A comparison of physiochemical property profiles of development and marketed oral drugs. J. Med. Chem. 2003, 46, 1250-1256.
20. CLOGP; Daylight Chemical Information Systems, Inc.: Mission Viejo, CA, 2002.
21. Ertl, P.; Rohde, B.; Selzer, P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem. 2000, 43, 3714-3717.
22. Lewell, X. Q.; Judd, D. B.; Watson, S. P.; Hann, M. M. RECAP-retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J. Chem. Inf. Comput. Sci. 1998, 38, 511-522.
23. Walters, W. P.; Stahl, M. T.; Murcko, M. A. Virtual Screening - an overview. Drug Discovery Today 1998, 3, 160-178.
24. Sheridan, R. P. Finding multiactivity substructures by mining databases of drug-like compounds. J. Chem. Inf. Comput. Sci. 2003, 43, 1037-1050.
25. JMP, version 4.0.4; SAS Institute Inc.: Cary, NC, 1989-2001.
26. Kelder, J.; Groothenhuis, P. D. J.; Bayada, D. M.; Delbressine, L. P.; Ploemen, J.-P. Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs. Pharm. Res. 1999, 16, 1514-1519.
27. Oprea, T. I. Current trends in lead discovery: Are we looking for the appropriate properties. J. Comput.-Aided Mol. Des. 2002, 16, 325-334.
28. Blake, J. F. Examination of the Computed Molecular Properties of Compounds Selected for Clinical Development. BioTechniques 2003, 34, S16-S20.
29. James, C. J.; Weininger, D.; Delany, J. Theory manual - SMARTS; Daylight Chemical Information Systems, Inc.: Mission Viejo, CA, 2001.
30. Derwent World Drug Index, 2001-2002 ed.; Derwent Publications: London, U.K., 2001.